Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-20

Study Completion Date

2015-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators propose to conduct a comparative pilot cognitive and psychiatric profiles of 10 patients Facio-Scapulo-Humeral Dystrophy (= FHSD) type 1 and 10 patients with type 2 FSHD study. For this, the investigators relied on observational components: FSHD2 patients appear more often present with psychiatric comorbidities and seem to have lower cognitive performance compared to FSHD1 patients. This was confirmed by a preliminary study on a small sample population of patients. It seems to exist mainly executive dysfunction associated with attention disorders in patients FSHD2. Moreover, their performance in IQ tests would be low in relation to their socio-educational and compared with patients FSHD1 level.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Psychoeducation Group Intervention for FND

NCT03857347

Functional Neurological Disorder

UNKNOWN NA

Exploring Transdiagnostic Psychological Processes in Functional Neurological Disorder

NCT06691295

Functionnal Neurological Disorder

COMPLETED

Clinical Characterization of Frequent Monogenic Forms of Neurodevelopmental Disorders

NCT04979182

Neurodevelopmental Disorders

UNKNOWN

Movement Disorders and Early Maladaptive Schemas

NCT03717376

Functional Movement Disorder Parkinson Disease Dystonic Disorders

COMPLETED

Facial Expression Recognition of Emotion and Categorization of Emotional Words in Gilles de la Tourette's Syndrome

NCT00664300

Gilles de la Tourette's Syndrome

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Muscular Dystrophy, Facioscapulohumeral

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FSHD patient

Group Type EXPERIMENTAL

Psychiatric test

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Psychiatric test

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age ≥ 18 years and \<75 years
* FSHD patients 1 or 2 with genetic confirmation

Exclusion Criteria

* Phosphokinase creatine level \> 5 time of the normal
* Patient as medical history :

* A history or active neurological disease likely to interfere with the interpretation of results
* a history of head trauma
* an infectious disease, hormonal, inflammatory or some deficiency may induce cognitive and / or psychiatric troubles
* Patient with cons-indication for performing a brain MRI
* Pregnant, parturient and lactating (producing a serum pregnancy test)

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No